Immunitybio Inc Revenue per Employee (IBRX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immunitybio inc   (NASDAQ: IBRX)
 

Immunitybio Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 93.91% in the second quarter 2026, year on year to cumulative value of $166 million, Immunitybio Inc 's revenue per employee grew on a trailing twelve months basis to $ 239,931. The productivity of Immunitybio Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 383 other companies have achieved higher revenue per employee. While Immunitybio Inc 's total ranking has deteriorated compared to the previous quarter from 1868 to 2932. Immunitybio Inc has 691 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IBRX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 93.91 % 167.64 % 406.95 % 425.07 % 2423.88 %
Sales per Employee (TTM) $ 239,931 204,019 163,948 119,472 81,910
IBRX's Total Ranking # 2932 # 1868 # 1188 # 915 # 1181
Seq. Revenue Change 15.91 % 15.47 % 19.41 % 21.33 % 59.99 %

IBRX Company Profile >> Back to IBRX Efficiency Comparisons >> Compare IBRX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 45
Healthcare Sector # 384
Overall Market # 2932

Revenue per Employee Statistics
High Average Low
$ 204,019 $ 17,834 $ 42
(Mar 31 2026)   (Jun 30 2018)



Financial Statements
Immunitybio Inc 's Revenue MRQ $ 51 Millions Visit IBRX's Income Statement
Immunitybio Inc 's Revenues TTM $ 166 Millions Visit IBRX's aggregate revenue growth
What are IBRX's Sales? Visit IBRX's Sales by Segment




Other Ratios
Immunitybio Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IBRX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IBRX's Competitors
Revenue per Employee for IBRX's Suppliers
Revenue per Employee for IBRX's Customers

You may also want to know
IBRX's Sales Growth Rates IBRX's Pe Price to earnings ratio IBRX's Receivables Turnover Ratio IBRX's Stock Quote
IBRX's Net Income Growth Rates IBRX's Ps Price to Sales ratio IBRX's Sales per Employee IBRX's Asset Turnover Ratio
IBRX's Net Margin IBRX's Pb Price to Book ratio IBRX's Financial Strength Ratios IBRX's Dividend Payout Ratio
Date modified: 2026-08-30T21:40:58+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Orthopediatrics Corp  417,405.32 $ 251.278  Million 602 
3m Company  416,198.35 $ 25,180.000  Million 60,500 
Solventum Corporation  415,500.00 $ 8,310.000  Million 20,000 
Teva Pharmaceutical Industries Limited  415,463.92 $ 14,105.000  Million 33,950 
Airsculpt Technologies Inc   415,217.63 $ 150.724  Million 363 
Tandem Diabetes Care Inc   414,920.80 $ 1,037.302  Million 2,500 
Idexx Laboratories Inc  413,981.09 $ 4,553.792  Million 11,000 
Talkspace Inc   412,426.42 $ 246.631  Million 598 
Adc Therapeutics Sa  412,352.33 $ 79.584  Million 193 
Quidelortho Corp  411,415.38 $ 2,674.200  Million 6,500 
Cryo cell International Inc   409,576.68 $ 31.128  Million 76 
Bausch and Lomb Corp  409,538.46 $ 5,324.000  Million 13,000 
Immucell Corporation  407,900.08 $ 29.777  Million 73 
Agilent Technologies inc   407,292.82 $ 7,372.000  Million 18,100 
Edwards Lifesciences Corporation  407,031.25 $ 6,512.500  Million 16,000 
Sotera Health Company  405,308.33 $ 1,215.925  Million 3,000 
Vanda Pharmaceuticals Inc   404,729.83 $ 215.721  Million 533 
Bio techne Corp  404,623.00 $ 1,213.869  Million 3,000 
Castle Biosciences Inc   404,618.35 $ 357.278  Million 883 
Axogen inc   403,816.72 $ 251.174  Million 622 
Xencor Inc  403,742.31 $ 104.973  Million 260 
Lensar Inc   401,760.00 $ 60.264  Million 150 
Lemaitre Vascular Inc   401,409.16 $ 262.923  Million 655 
Verrica Pharmaceuticals Inc   398,960.53 $ 30.321  Million 76 
Yunhong Green Cti Ltd   397,346.15 $ 20.662  Million 52 
Innovage Holding Corp   395,882.80 $ 989.707  Million 2,500 
Medtronic Plc  395,178.95 $ 37,542.000  Million 95,000 
Repligen Corp  392,550.50 $ 785.101  Million 2,000 
Nrc Health  392,145.66 $ 139.996  Million 357 
Aligos Therapeutics Inc   384,365.85 $ 31.518  Million 82 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.